EOM PHARMACEUTICAL HLDNGS (IMUC) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 115 160 sessions, September 10, 2025 to September 11, 2026
- Largest daily move
- +174.6% close of January 2, 2026
- 1-year change
- +113.9% closing prices, September 10, 2025 to September 11, 2026
- 5-year change
- -67.3% closing prices, September 10, 2021 to September 11, 2026
Company Description
EOM PHARMACEUTICAL HLDNGS (OTC: IMUC) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $11.3M.
IMUC has gained 113.9% over the past year. The last closing price was $0.1899.
For FY2017, EOM PHARMACEUTICAL HLDNGS reported revenue of $0 with net income of -$14.3M.
This page collects what Stock Titan holds for IMUC, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
EOM PHARMACEUTICAL HLDNGS (IMUC) closed at $0.1899 on September 11, 2026. Over the past 12 months, the price has gained 113.9%.
IMUC Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
EOM PHARMACEUTICAL HLDNGS has 4 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, covid-19, acquisition. View all IMUC news →
SEC Filings
Financial Highlights
operating income reached -$21.2M, and net income was -$14.3M. The company generated -$16.7M in operating cash flow. With a current ratio of 2.97, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in EOM PHARMACEUTICAL HLDNGS (IMUC) currently stands at 40 shares, representing 0.0% of the float. Since September 2025, short interest has decreased by 48.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for EOM PHARMACEUTICAL HLDNGS (IMUC) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
IMUC Company Profile & Sector Positioning
EOM PHARMACEUTICAL HLDNGS (IMUC) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing IMUC often look at related companies in the same sector, including SIRONA BIOCHEM CORP ORD (SRBCF), GENFLOW BIOSCIENCES PLC (GENFF), PREVECEUTICAL MED INC NEW (PRVCF), ZEO SCIENTIFIX INC (ZEOX), and MARVEL BIOSCIENCES CORP (MBCOF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IMUC's relative position within its industry.